Recombinant SARS-CoV-2 Nucleocapsid Protein for Diagnostic Testing
The new recombinant SARS-CoV-2 nucleocapsid protein is for covid-19 diagnostic test manufacturers, vaccine developers, and researchers globally.
Read MoreSearch Results for: covid-19
FDA Authorizes Rutgers Saliva Test for Coronavirus
The new saliva collection method will allow for broader population screening for covid-19 than the current method of nose and throat swabs.
Read More
BARDA Awards Contract for Rapid Coronavirus In-Home Self-Test
No instrumentation or trained personnel would be needed to administer the test or to read the results.
Read More
Total Nucleic Acid Extraction for Pathogen Detection
The kit is particularly suitable for total nucleic acid extraction for detecting SARS-CoV-2, the virus that causes covid-19.
Read More
FDA Updates Guidance to Address Urgent Need for Blood During the Pandemic
Based on recently completed studies and epidemiologic data, FDA has concluded that current policies regarding certain donor eligibility criteria can be modified without compromising the safety of the blood supply.
Read More